Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

EC approves Johnson & Johnson's $30bn acquisition of Actelion The European Commission (EC) has approved Johnson & Johnson's proposed $30bn acquisition of Actelion Pharmaceuticals, subject to conditions Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

GlobalData says acute myeloid leukemia market will cross $1.5bn by 2026
The acute myeloid leukemia (AML) market in the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will grow more than three times from $406m in 2016 to more than $1.5bn by 2026, reflecting a compound annual growth rate of 14%, as per research and consulting firm GlobalData.
Drug Research > Drug Delivery > News
Sarepta, BioMarin settle patent litigation over DMD exon-skipping drugs
By PBR Staff Writer
Sarepta Therapeutics and BioMarin Pharmaceutical have settled a global patent litigation relating to the use of the former’s Exondys 51 and all future exon-skipping products for the treatment of Duchenne muscular dystrophy (DMD).
Drug Research > Drug Delivery > News

Drug Discovery & Development

UK awards more than £120m for global health research
The UK’s Department of Health has announced that 33 research units and groups will get over £120m funding for global health research.
Drug Research > Drug Discovery & Development > News
Mayo Clinic, nference launch startup company for drug development
By PBR Staff Writer
Mayo Clinic and nference have jointly formed a new startup to discover and develop therapies for diseases with unmet medical need using artificial intelligence (AI).
Drug Research > Drug Discovery & Development > News